R3HDM1 haploinsufficiency is associated with mild intellectual disability.
Daisuke FukushiMie InabaKimiko KatohYasuyo SuzukiYasushi EnokidoNoriko NomuraYoshihito TokitaShin HayashiSeiji MizunoKenichiro YamadaNobuaki WakamatsuPublished in: American journal of medical genetics. Part A (2021)
R3HDM1 (R3H domain containing 1) is an uncharacterized RNA-binding protein that is highly expressed in the human cerebral cortex. We report the first case of a 12-year-old Japanese male with haploinsufficiency of R3HDM1. He presented with mild intellectual disability (ID) and developmental delay. He had a pericentric inversion of 46,XY,inv(2)(p16.1q21.3)dn with breakpoints in intron 19 of R3HDM1 (2q21.3) and the intergenic region (2p16.1). The R3HDM1 levels in his lymphoblastoid cells were reduced to approximately half that of the healthy controls. However, the expression of MIR128-1, in intron 18 of R3HDM1, was not affected via the pericentric inversion. Knockdown of R3HDM1 in mouse embryonic hippocampal neurons suppressed dendritic growth and branching. Notably, the Database of Genomic Variants reported the case of a healthy control with a 488-kb deletion that included both R3HDM1 and MIR128-1. miR-128 has been reported to inhibit dendritic growth and branching in mouse brain neurons, which directly opposes the novel functions of R3HDM1. These findings suggest that deleting both R3HDM1 and MIR128-1 alleviates the symptoms of the disease caused by loss-of-function mutations in R3HDM1 only. Thus, haploinsufficiency of R3HDM1 in the patient may be the cause of the mild ID due to the genetic imbalance between R3HDM1 and MIR128-1.
Keyphrases
- intellectual disability
- cell proliferation
- long non coding rna
- long noncoding rna
- binding protein
- autism spectrum disorder
- poor prognosis
- endothelial cells
- magnetic resonance imaging
- spinal cord
- copy number
- induced apoptosis
- brain injury
- signaling pathway
- dna methylation
- adverse drug
- functional connectivity
- pi k akt
- induced pluripotent stem cells